EXPERTISE
Life Sciences & Healthcare

Kinstellar advises on the largest pharma transaction of 2017 in CEE

April 2018 – Kinstellar has successfully advised Penta Investments, the owner of the Dr. Max pharmacy chain operating in the Central and Eastern European region, on the acquisition of A&D Pharma, the largest pharmacy group in Romania. A&D Pharma operates more than 600 pharmacies and is the leading full-line wholesale business with marketing & sales activities across the region, employing more than 4,500 people. The total value of the transaction was not officially disclosed.

Kinstellar has coordinated the merger control advice, which included the merger notifications in Romania, Bulgaria, the Czech Republic and Poland. The merger clearance in Romania was subject to commitments.

The team was led by Tomáš Čihula, Counsel in Prague and the head of the Life Sciences & Healthcare sector. Other key team members were Iustinian Captariu, Partner in Bucharest and Dessislava Fessenko, Of Counsel in Sofia.

For more information please contact Tomáš Čihula, at .